Common Contracts
2 similar License Agreement contracts by Spero Therapeutics, Inc.
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • October 23rd, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • New York
This Amended and Restated License Agreement (this “Agreement”), dated as of June 28, 2017 (the “Effective Date”), is made by and between Northern Antibiotics Oy (Ltd.), a corporation organized under the laws of Finland (“Northern”), and Spero Potentiator, Inc., a Delaware corporation (“Spero”). Northern and Spero are sometimes hereinafter referred to each as a “Party” and collectively as the “Parties.”
AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • October 6th, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • New York
This Amended and Restated License Agreement (this “Agreement”), dated as of June 28, 2017 (the “Effective Date”), is made by and between Northern Antibiotics Oy (Ltd.), a corporation organized under the laws of Finland (“Northern”), and Spero Potentiator, Inc., a Delaware corporation (“Spero”). Northern and Spero are sometimes hereinafter referred to each as a “Party” and collectively as the “Parties.”
